Global Electronic Drug Delivery Systems Market Size and Forecast 2024-2033|Gerresheimer AG, Amgen Inc., Medtronic PLC, Novo Nordisk A/S, Insulet Corporation,

The Electronic Drug Delivery Systems Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Electronic Drug Delivery Systems Market:

https://www.thebusinessresearchcompany.com/report/electronic-drug-delivery-systems-global-market-report

According to The Business Research Company’s Electronic Drug Delivery Systems Global Market Report 2024, The electronic drug delivery systems market size has grown strongly in recent years. It will grow from $10.54 billion in 2023 to $11.45 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The  growth in the historic period can be attributed to risen chronic diseases incidence, aging population, patient preference for non-invasive delivery, healthcare cost containment, clinical advancements and validation.

The electronic drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $16.12 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing drug personalization, rising global healthcare expenditure, patient-centric healthcare approach, emergence of targeted therapies, supportive regulatory environment, advancements in remote patient monitoring. Major trends in the forecast period include incorporation of artificial intelligence (ai), biocompatible materials and implantable devices, customization for specific therapeutic areas, regulatory advancements and standardization, collaborations between pharma and tech companies.

The rising prevalence of chronic disease is expected to propel the growth of the electronic drug delivery systems market going forward. Chronic disease refers to a condition or disease that lasts for more than a year and requires ongoing medical treatment. Electronic drug delivery systems are used for regulating drug doses and make monitoring drug doses easy for people who suffer from chronic diseases. For instance, in January 2023, according to the National Library of Medicine, a US-based agency, the number of people in the US aged 50 and older who have at least 1 chronic condition would increase to 142.66 million by 2050.   Therefore, the rising prevalence of chronic diseases will drive the electronic delivery system market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=10734&type=smp

The electronic drug delivery systems market covered in this report is segmented –

1) By Type: Electronic Infusion Pumps, Electronic Injection Pens, Electronic Auto-Injectors, Electronic Inhalers, Electronic Capsules, Other Types

2) By Component: Sensors, Wireless Communicator And Antennas, Micro Pumps And Flow Regulators, Drug Reservoir, Microcontroller, Other Components

3) By System Type: Battery-Powered Systems, Rechargeable Systems

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By Application: Diabetes, Cardiovascular Disease, Respiratory Disorders, Multiple Sclerosis, Other Applications

Technologically advanced, minimally invasive drug delivery systems are a key trend in the electronic drug delivery system market. Major companies in the electronic drug delivery market are launching drug delivery systems that are innovative and technologically innovative to sustain their position in the electronic drug delivery systems market. For instance, in March 2022, Evonik Industries AG, a Germany-based specialty chemicals company, launched EUDRATEC SoluFlow, which is a new microparticle technology to enhance the solubility of active pharmaceutical ingredients in oral drug products. The new technology is one of the company’s oral drug delivery technologies for treating diseases such as cancer, cardiovascular diseases, infectious diseases, and diabetes.

The electronic drug delivery systems market report table of contents includes:

1. Executive Summary

2. Electronic Drug Delivery Systems Market Characteristics

3. Electronic Drug Delivery Systems Market Trends And Strategies

4. Electronic Drug Delivery Systems Market – Macro Economic Scenario

5. Global Electronic Drug Delivery Systems Market Size and Growth

.

.

.

26. South America Electronic Drug Delivery Systems Market

27. Brazil Electronic Drug Delivery Systems Market

28. Middle East Electronic Drug Delivery Systems Market

29. Africa Electronic Drug Delivery Systems Market

30. Electronic Drug Delivery Systems Market Competitive Landscape And Company Profiles

Top Major Players:

• Gerresheimer AG
• Amgen Inc
• Medtronic PLC
• Novo Nordisk A/S
• Insulet Corporation

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model